Salon (website)

Snopes Co-Owners Acquire All Remaining Shares of the Company, Bringing Total Stake to 100%

Retrieved on: 
Friday, September 23, 2022

The relationship with the company started in 2016 when Richmond and Schoentrup, along with three other individuals, acquired a 50% stake in the company.

Key Points: 
  • The relationship with the company started in 2016 when Richmond and Schoentrup, along with three other individuals, acquired a 50% stake in the company.
  • David Mikkelson, who co-founded the company in 1994, held the remaining shares.
  • Effective Sept. 16, Mikkelson stepped down as chief executive officer and stepped down from the Snopes Board of Directors.
  • Richmond, who has served as a board member of Snopes since 2018, has assumed the role of chief executive officer.

Annabelle Gurwitch to Emcee Lung Cancer Research Foundation Gala

Retrieved on: 
Wednesday, September 21, 2022

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Ms. Annabelle Gurwitch, who was diagnosed with Stage IV EGFR non-small cell lung cancer when she went in for a COVID-19 test in 2020, will emcee the Lung Cancer Research Foundation's (LCRF) 2022 Evening of Innovation Gala, honoring Dr. Brendon M. Stiles. Ms. Gurwitch recently shared remarks at the opening plenary session of International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer in Vienna, Austria.

Key Points: 
  • Actor, activist, and author teams up with the Lung Cancer Research Foundation to increase awareness of lung cancer and honor Dr. Brendon M. Stiles for his service to the foundation and the lung cancer community
    NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Ms. Annabelle Gurwitch, who was diagnosed with Stage IV EGFR non-small cell lung cancer when she went in for a COVID-19 test in 2020, will emcee the Lung Cancer Research Foundation's (LCRF) 2022 Evening of Innovation Gala, honoring Dr. Brendon M. Stiles.
  • "Dr. Stiles' personal and professional contribution to lung cancer patients and his commitment to accelerating lung cancer research is immeasurable.
  • The Lung Cancer Research Foundation (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer.
  • LCRF's mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer.

Relay Robotics Secures $10 Million Financing

Retrieved on: 
Monday, May 2, 2022

Relay Robotics, Inc. a new corporation formed by the acquisition of leading robotics developer Savioke announced the completion of a $10,000,000 Series A Financing and the appointment of veteran technology executive, Michael ODonnell, as Chairman and Chief Executive Officer.

Key Points: 
  • Relay Robotics, Inc. a new corporation formed by the acquisition of leading robotics developer Savioke announced the completion of a $10,000,000 Series A Financing and the appointment of veteran technology executive, Michael ODonnell, as Chairman and Chief Executive Officer.
  • Savioke Co-Founder, Steve Cousins, will become Chief Technology Officer of Relay Robotics and lead the companys product strategy and innovation efforts.
  • With COVID-19 retreating, the markets Relay Robotics serves (hospitality, healthcare, and real estate), are poised for a robust recovery.
  • Relay Robotics and its affiliates have been technology leaders in robotics since 2013 and hold 10 U.S. patents.

CATALYST Presents Foundation announces collaboration with Queen's University's Faculty of Health Sciences to host first in-person CATALYST Summit in Kingston, Ontario

Retrieved on: 
Monday, August 16, 2021

CATALYST Summit 2022 event founder, David Harder, saw the potential to work with the Faculty of Health Sciences at Queen's University when the opportunity presented itself in the spring.

Key Points: 
  • CATALYST Summit 2022 event founder, David Harder, saw the potential to work with the Faculty of Health Sciences at Queen's University when the opportunity presented itself in the spring.
  • "It fits with our initiative to present CATALYST as Canada's premiere, 'must attend' medical, research, and business psychedelics conference."
  • Stay tuned for more details on this new and exciting component to CATALYST Summit 2022.
  • Rakesh Jain, MD, MPH, Clinical Professor, Department of Psychiatry, Texas Tech Health Sciences Centre, School of Medicine, Midland, Texas.